Concepedia

David Jonathan Bennett

DJ

39

Publications

2.4K

Citations

24

H-Index

1980

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

NHS Lanarkshire

Merck (United Kingdom)

United States Military Academy

David Jonathan Bennett is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryDrug DiscoveryNatural SciencesMedicinal ChemistryPharmacotherapyOrganic ChemistryDrug DevelopmentBioorganic Chemistry

Publications per year

1980–2024

39

Publications

39

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

Antitumor Activity, Immunology, Immunoediting +19

Cyclodextrin-Derived Host Molecules as Reversal Agents for the Neuromuscular Blocker Rocuronium Bromide: Synthesis and Structure−Activity Relationships

Julia M. Adam, David Jonathan Bennett, A. Bom et al. · Journal of Medicinal Chemistry · 2002 · 230 citations

A Selective Synthesis of 2,2-Difluorobicyclo[1.1.1]pentane Analogues: “BCP-F<sub>2</sub>”

Xiaoshen Ma, David L. Sloman, Yongxin Han et al. · Organic Letters · 2019 · 144 citations

General access to cubanes as benzene bioisosteres

Mario P. Wiesenfeldt, James A. Rossi‐Ashton, Ian B. Perry et al. · Nature · 2023 · 141 citations · Full text

Bioorganic Chemistry, Biochemistry, Natural Sciences +4

A kinase-cGAS cascade to synthesize a therapeutic STING activator

John A. McIntosh, Zhijian Liu, Brian M. Andresen et al. · Nature · 2022 · 125 citations

Signal Transduction, Biochemistry, Receptor Tyrosine Kinase +5

Rows per page

1–5 of 39